Aurora Cannabis Inc. (NASDAQ:ACB – Free Report) – Research analysts at Roth Capital issued their Q1 2026 earnings per share (EPS) estimates for Aurora Cannabis in a research report issued on Thursday, February 6th. Roth Capital analyst W. Kirk anticipates that the company will earn $0.17 per share for the quarter. The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.10) per share. Roth Capital also issued estimates for Aurora Cannabis’ Q2 2026 earnings at $0.02 EPS, Q3 2026 earnings at $0.40 EPS and Q4 2026 earnings at $0.29 EPS.
Several other research analysts also recently commented on ACB. TD Cowen began coverage on shares of Aurora Cannabis in a research report on Wednesday, December 11th. They set a “buy” rating for the company. TD Securities raised Aurora Cannabis to a “strong-buy” rating in a report on Thursday, December 12th.
Aurora Cannabis Price Performance
Shares of NASDAQ:ACB opened at $6.25 on Friday. The company has a current ratio of 3.83, a quick ratio of 1.88 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $342.86 million, a PE ratio of -8.22 and a beta of 1.84. The firm has a 50 day moving average of $4.24 and a 200-day moving average of $5.16. Aurora Cannabis has a 12 month low of $2.84 and a 12 month high of $9.35.
Aurora Cannabis (NASDAQ:ACB – Get Free Report) last released its earnings results on Wednesday, February 5th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.15. Aurora Cannabis had a negative return on equity of 2.19% and a negative net margin of 17.47%.
Institutional Investors Weigh In On Aurora Cannabis
A number of hedge funds have recently made changes to their positions in ACB. SBI Securities Co. Ltd. acquired a new position in Aurora Cannabis during the 4th quarter worth approximately $31,000. Cubist Systematic Strategies LLC bought a new stake in shares of Aurora Cannabis during the second quarter worth $50,000. Wealthspire Advisors LLC bought a new stake in Aurora Cannabis during the 4th quarter worth $149,000. Finally, Tidal Investments LLC increased its holdings in Aurora Cannabis by 2.7% in the 3rd quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock worth $7,905,000 after purchasing an additional 34,988 shares in the last quarter. 47.63% of the stock is currently owned by institutional investors and hedge funds.
Aurora Cannabis Company Profile
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Articles
- Five stocks we like better than Aurora Cannabis
- What is diluted earnings per share (Diluted EPS)?
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- 3 Best Fintech Stocks for a Portfolio Boost
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.